Scholarlink

Justification <p>Recent advancements in vaccinology and the introduction of new vaccines warrant a revision of the existing immunization guidelines.</p> Objectives <p>To review and revise the IAP recommendations (2023) on immunization of children aged 0 to 18&#xa0;years and issue recommendations on existing and new vaccines.</p> Process <p>The Advisory Committee on Vaccines and Immunization Practices (ACVIP) of the Indian Academy of Pediatrics (IAP) discussed the updates and drafted evidence-based consensus recommendations after several rounds of meetings convened both in-person and virtually. The contents were finalized during the meeting held at the IAP Office, Navi Mumbai, on November 23, 2025.</p> Recommendations <p>The major changes include recommendation of replacing the quadrivalent (A/H1N1, A/H3N2, B/Victoria, B/Yamagata) influenza vaccines with trivalent (A/H1N1, A/H3N2, B/Victoria) influenza vaccines. The use of nirsevimab for respiratory syncytial virus is recommended for high-risk cases, after consultation with the parents. Immunocompetent girls aged 9 to 15&#xa0;years may receive a single dose of the human papilloma virus (HPV) vaccine. A 5-dose intramuscular rabies vaccination schedule administered on days 0, 3, 7, 14, and 28 is recommended for post-exposure prophylaxis (PEP), along with rabies immunoglobulin (RIG) or rabies monoclonal antibody (RMAb) based on the category of exposure.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Indian Academy of Pediatrics (IAP) Advisory Committee on Vaccines and Immunization Practices (ACVIP): Recommended Immunization Schedule (2025) and Update on Immunization for Children Aged 0 Through 18 Years

  • 期刊论文

  • 发表日期：

    2026年4月9日

查看全文
  • Digant D. Shastri,
  • Shashi Kant Dhir,
  • B. Rajsekhar,
  • Sumitha Nayak,
  • Chandra Mohan Kumar,
  • Anurag Agarwal,
  • Swapan Kumar Ray,
  • R. Krishna Mohan,
  • Bhadresh R. Vyas,
  • Raman Gangakhedkar,
  • Rajeshwar Dayal,
  • Vijay Bade,
  • G. V. Basavaraja,
  • Vasant Khalatkar,
  • Yogesh N. Parikh,
  • Neelam Mohan

摘要

Justification

Recent advancements in vaccinology and the introduction of new vaccines warrant a revision of the existing immunization guidelines.

Objectives

To review and revise the IAP recommendations (2023) on immunization of children aged 0 to 18 years and issue recommendations on existing and new vaccines.

Process

The Advisory Committee on Vaccines and Immunization Practices (ACVIP) of the Indian Academy of Pediatrics (IAP) discussed the updates and drafted evidence-based consensus recommendations after several rounds of meetings convened both in-person and virtually. The contents were finalized during the meeting held at the IAP Office, Navi Mumbai, on November 23, 2025.

Recommendations

The major changes include recommendation of replacing the quadrivalent (A/H1N1, A/H3N2, B/Victoria, B/Yamagata) influenza vaccines with trivalent (A/H1N1, A/H3N2, B/Victoria) influenza vaccines. The use of nirsevimab for respiratory syncytial virus is recommended for high-risk cases, after consultation with the parents. Immunocompetent girls aged 9 to 15 years may receive a single dose of the human papilloma virus (HPV) vaccine. A 5-dose intramuscular rabies vaccination schedule administered on days 0, 3, 7, 14, and 28 is recommended for post-exposure prophylaxis (PEP), along with rabies immunoglobulin (RIG) or rabies monoclonal antibody (RMAb) based on the category of exposure.